Emcure Q2 FY27 Profit Rises 29% as Overseas Sales Jump 35%
Emcure Pharmaceuticals Q2 FY27 profit rose 29.3% to ₹325.1 crore as revenue grew 24.3% to ₹2,820.5 crore, led by 34.5% growth in international sales.
Emcure Pharmaceuticals Q2 FY27 profit rose 29.3% to ₹325.1 crore as revenue grew 24.3% to ₹2,820.5 crore, led by 34.5% growth in international sales.
Mankind Pharma’s Q2 FY27 net profit rose 37.7% to ₹716 crore on 17.3% revenue growth to ₹4,338 crore, led by cardiac and anti-diabetes demand in India, 33% export growth and a 210 bps EBITDA margin expansion to 27.1%.
Cipla’s consolidated net profit fell about 35% year-on-year to ₹878 crore in Q2 FY27 on revenue of ₹7,404 crore, but its One India business logged its highest-ever quarterly sales, margins improved sequentially, and the company is leaning on its US inhalation pipeline and a Keytruda biosimilar partnership for growth.